We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Baxter International Inc. is developing a ...
DEERFIELD, Ill., December 11, 2001 - Baxter Healthcare Corporation announced today it has received clearance from the U.S. Food and Drug Administration (FDA) to market its HomeChoice Pediatric ...
First patients have been enrolled in the clinical trial for next generation dialysis technology Innovative system designed to improve home dialysis experience and simplify therapy management New ...
Baxter has received clearance from the FDA for the latest version of its automated peritoneal dialysis system designed for home use, combining it with a digital platform that aims to help patients ...
With one in four APD patients globally benefitting from Baxter’s two-way remote patient management technology, Sharesource offers patients and clinicians the ability to stay closely connected to ...
The COVID-19 pandemic may have accelerated the push toward home-based treatments, but that’s been a lasting goal for dialysis provider DaVita Kidney Care. Now, the company is gearing up for the long ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio After showing steady growth beginning in ...
In a retrospective study of home peritoneal dialysis patients in Colombia, use of Baxter’s Sharesource remote patient management (telehealth) platform was associated with a 56% reduction in technique ...
Baxter announced a voluntary recall of a single lot of DIANEAL PD-2 Peritoneal Dialysis Solution with 1.5% Dextrose 6000mL (Ambu-Flex II). The recall was initiated after particulate matter, identified ...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced U.S. Food and Drug Administration (FDA) clearance of the Homechoice Claria ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results